218 related articles for article (PubMed ID: 22554404)
1. Monitoring medicines use: the role of the clinical pharmacologist.
Williams D
Br J Clin Pharmacol; 2012 Oct; 74(4):685-90. PubMed ID: 22554404
[TBL] [Abstract][Full Text] [Related]
2. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
[TBL] [Abstract][Full Text] [Related]
3. Drug safety in relation to efficacy: the view of a clinical pharmacologist.
Sjöqvist F
Pharmacol Toxicol; 2000; 86 Suppl 1():30-2. PubMed ID: 10905752
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
Schäublin M
Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
[TBL] [Abstract][Full Text] [Related]
5. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Krähenbühl S
Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
[TBL] [Abstract][Full Text] [Related]
6. Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content.
Herrera Comoglio R
Br J Clin Pharmacol; 2020 Apr; 86(4):779-790. PubMed ID: 31770452
[TBL] [Abstract][Full Text] [Related]
7. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
Kunac DL; Tatley MV
Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
[TBL] [Abstract][Full Text] [Related]
8. Improving pediatric drug safety: need for more efficient clinical translation of pharmacovigilance knowledge.
Castro-Pastrana LI; Carleton BC
J Popul Ther Clin Pharmacol; 2011; 18():e76-88. PubMed ID: 21467599
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoepidemiology and its input to pharmacovigilance.
Faillie JL; Montastruc F; Montastruc JL; Pariente A
Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
[TBL] [Abstract][Full Text] [Related]
11. The Erice Manifesto: for global reform of the safety of medicines in patient care.
Drug Saf; 2007; 30(3):187-90. PubMed ID: 17343426
[TBL] [Abstract][Full Text] [Related]
12. Review of the Methods to Obtain Paediatric Drug Safety Information: Spontaneous Reporting and Healthcare Databases, Active Surveillance Programmes, Systematic Reviews and Meta-analyses.
Gentili M; Pozzi M; Peeters G; Radice S; Carnovale C
Curr Clin Pharmacol; 2018; 13(1):28-39. PubMed ID: 29412117
[TBL] [Abstract][Full Text] [Related]
13. Knowledge creation about ADRs--turning the perspective from the rear mirror to the projector?
Aagaard L; Soendergaard B; Stenver DI; Hansen EH
Br J Clin Pharmacol; 2008 Mar; 65(3):364-76. PubMed ID: 17961195
[TBL] [Abstract][Full Text] [Related]
14. [Safety of medicinal products and reporting of adverse drug reactions].
Skibicka I; Maciejczyk A
Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
[TBL] [Abstract][Full Text] [Related]
15. Veterinary pharmacovigilance in India: A need of hour.
Kumar R; Kalaiselvan V; Verma R; Kaur I; Kumar P; Singh GN
Indian J Pharmacol; 2017; 49(1):2-3. PubMed ID: 28458414
[TBL] [Abstract][Full Text] [Related]
16. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
Liu R; Zhang P
BMC Med Inform Decis Mak; 2019 Dec; 19(1):279. PubMed ID: 31849321
[TBL] [Abstract][Full Text] [Related]
17. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria.
Shakir SA; Layton D
Drug Saf; 2002; 25(6):467-71. PubMed ID: 12071785
[TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance in China: development and challenges.
Zhao Y; Wang T; Li G; Sun S
Int J Clin Pharm; 2018 Aug; 40(4):823-831. PubMed ID: 30051225
[TBL] [Abstract][Full Text] [Related]
19. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
[TBL] [Abstract][Full Text] [Related]
20. Pharmacovigilance for children's sake.
Star K; Edwards IR
Drug Saf; 2014 Feb; 37(2):91-8. PubMed ID: 24446277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
